Abintus Bio Patents – Insights & Stats (Updated 2023)

Abintus Bio has a total of 20 patents globally, out of which 1 has been granted. Of these 20 patents, more than 95% patents are active.The United States of America seems to be the main focused R&D center and also the origin country of Abintus Bio.

Abintus Bio was founded in the year 2020. Abintus Bio is a preclinical stage gene therapy company that engages in the field of in vivo immune cell reprogramming. The company’s goal is to improve patient outcomes and access by developing products that manipulate immune cells in their natural habitat. Its main goal is to find and create a portfolio of best-in-class product candidates that use patented vectors and associated technologies to directly reprogrammed immune cells in their natural environments.

Do read about some of the most popular patents of Abintus Bio which have been covered by us in this article and also you can find Abintus Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abintus Bio patent portfolio.

How many patents does Abintus Bio have?

Abintus Bio has a total of 20 patents globally. These patents belong to 3 unique patent families. Out of 20 patents, 19 patents are active.

How Many Patents did Abintus Bio File Every Year?

Abintus Bio Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAbintus Bio Applications FiledAbintus Bio Patents Granted
20208
202110
202211

How many Abintus Bio patents are Alive/Dead?

Worldwide Patents

Abintus Bio Patents Portfolio

How Many Patents did Abintus Bio File in Different Countries?

Abintus Bio Worldwide Patents

Countries in which Abintus Bio Filed Patents

CountryPatents
United States Of America2
India2
Australia2
Canada2
Singapore2
China2
Europe2
Israel2
South Africa1
Brazil1
Philippines1

Where are Research Centers of Abintus Bio Patents Located?

List of Abintus Bio Patents

Abintus BioTitle
US20230304031A1Vectors And Methods For In Vivo Transduction
US20220090132A1Car T Cell Methods And Constructs
EP4149495A1Vectors And Methods For In Vivo Transduction
EP3906311A4Car T Cell Methods And Constructs
CN115968300AVectors And Methods For In Vivo Transduction
CN113382741ACar T-Cell Methods And Constructs
CA3176697A1Vectors And Methods For In Vivo Transduction
CA3125201A1Car T Cell Methods And Constructs
AU2021273253A1Vectors And Methods For In Vivo Transduction
AU2020205000A1Car T Cell Methods And Constructs
IN202217071240AVectors And Methods For In Vivo Transduction
IN202117033063ACar T Cell Methods And Constructs
ZA202103899BCar T Cell Methods And Constructs
SG11202260106TAVectors And Methods For In Vivo Transduction
IL297514AVectors And Methods For In Vivo Transduction
PH12021551619A1Car T Cell Methods And Constructs
BR112021013180A2Pharmaceutical Composition, Non-Replicating Viral Vector, And, Method To Provide Adoptive Cell Therapy
IL284461ACar T Cell Methods And Constructs
SG11202107246TACar T Cell Methods And Constructs
WO2021231505A1Vectors And Methods For In Vivo Transduction

What are Abintus Bio key innovation segments?

What Technologies are Covered by Abintus Bio?

The chart below distributes patents filed by Abintus Bio in different countries on the basis of the technology protected in patents. It also represents the markets where Abintus Bio thinks it’s important to protect particular technology inventions.

R&D Focus: How has Abintus Bio search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Abintus Bio?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.